Overview

This book functions as a clinician’s guide to the use of cannabidiol (CBD) in the treatment of mental health conditions. It conveys the scientific evidence of efficacy of CBD as well as THC and addresses the social stigma attached to its medical use. The book describes the endocannabinoid system, how stress and the endocannabinoid system interact and key constituents, pharmacokinetics and safety aspects of medicinal cannabis, focusing on CBD and THC. Chapters on specific mental health conditions describe the underpinning pathomechanisms including how the endocannabinoid system is involved, and summarises the scientific evidence including animal and human research for the use of CBD and THC in treatment of such conditions. Topics covered include anxiety, depression, post-traumatic stress disorder, insomnia, Alzheimer's Disease and autism spectrum disorder. Chapters also discuss treatment guidelines and case studies. Unique and focused, Medicinal Cannabis and CBD in Mental Healthcare is an invaluable reference for medical practitioners seeking to adopt CBD-use in their treatment plans.

Full Product Details

Author:   Kylie O'Brien ,  Philip Blair
Publisher:   Springer Nature Switzerland AG
Imprint:   Springer Nature Switzerland AG
Edition:   1st ed. 2021
Weight:   1.114kg
ISBN:  

9783030785581

ISBN 10:   3030785580
Pages:   576
Publication Date:   28 October 2021
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   Manufactured on demand  
We will order this item for you from a manufactured on demand supplier.

Table of Contents

Introduction Endocannabinoid system: will cover what the endocannabinoid system is, the concept of endocannabinoid deficiency Overview of cannabis: will cover what is cannabis, historical use in mental health, active constituents with a focus on CBD (but also including THC, terpenes) Pharmacokinetics and Safety: including potential toxicity, recreational cannabis vs medicinal uses, drug-herb interactions Stress and Anxiety: will cover how CBD can reduce anxiety (mechanisms of action), and the scientific evidence for efficacy. It will also include guidance on dosing, and a case study (1-2). Depression: will cover how CBD can reduce depression (mechanisms of action), and the scientific evidence for efficacy. It will also include guidance on dosing, and a case study. Sleep disorders: will cover how CBD can be used to treat insomnia and sleep apnoea (mechanisms of action), and the scientific evidence for efficacy. It will also include guidance on dosing, and a case study. PTSD: will cover how CBD can be used to treat PTSD (mechanisms of action), and the scientific evidence for efficacy. It will also include guidance on dosing, and a case study Co-morbid chronic pain and mental health: will cover how CBD can be used to treat chronic pain and co-morbid mental health issues- sleep and depression, and the scientific evidence for efficacy. It will also include guidance on dosing, and 2 case studies. Dementia: will cover the evidence for its efficacy in treating dementia including Alzheimer’s Disease. ADHD, Autism End of life and existential matters- the role of cannabis including CBD Conclusion: will cover a holistic approach to treatment of mental health that includes cannabis then conclude the book.

Reviews

Author Information

Professor Kylie O’Brien PhDKylie O’Brien PhD Adjunct Professor Torrens University Director of Research & Education International College of Cannabinoid Medicine Email: kylie@iccm.co Phone: +61 412 077689 Dr Philip Blair, MDDr. Philip Blair, MD, Colonel (US Army Ret) CEO of AbleDoc, Inc, International Medical Consultant Chief Medical Officer, International College of Cannabinoid Medicine Chief Medical Officer, Releaf Clinics, Australia Chief Science Officer for Harvest 360 Castle Rock, Washington email: abledoc@mac.com

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions